LETTERS TO THE JOURl\J"AL that the eyelids were the most commonly affected region and only six cases had a direct conjunctival localisation. Unfortunately the authors did not report how these lesions were treated. In another report of conjunctival involvement with mycosis fungoides, O'Day et al? suggested that superficial X-ray therapy can be used to treat these conjunctival localisations of mycosis fungoides, although the authors recog nised that side effects such as cataract formation should be anticipated.
. Sheets of medium-sized atypical lymphoid cells involving the dermal stroma and Pautrier microabscesses in the epithelium (haematoxylin-eosin, X15).
higher magnification, some of these lymphocytes showed large convoluted nuclei. Immunohistochem ical study of the tissue showed that the infiltrating lymphocytes were of T-cell origin (CD3+ and CD4+).
These data led to the diagnosis of conjunctival localisation with mycosis fungoides. Therapy with low doses of rINF-a2a (3 million units 3 times a week) and 25 mg etretinate 3 times a week was reinstated and led to a gradual regression of cutaneous plaques. A year later, the patient is still on this therapy and no eye or skin relapses have occurred.
Comment
Eye anomalies are common in patients with mycosis fungoides.
z We report a patient with bilateral optic nerve sheath meningiomas whose unresectable tumours were treated by hormonal manipulation.
Case Report Radiological Investigations. Plain radiographs of the optic foramina showed no evidence of enlargement.
A CT scan revealed non-contiguous bilateral 
